The Patent Finder

Terms ending in 2026

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,709,511Novel Benzothiazolone Derivatives
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,562,017Novel Hydrogen Sulfate Salt
In force
 · High confidence
Alexion Pharma International Operations LimitedIn forceHigh confidence
US 7,425,556Compounds and Uses Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 7,465,795Compounds and Uses Thereof
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
4 of 4 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited